# Vertex Stock Alpha and Beta Analysis

VRTX | Stock | ## USD 294.52 2.36 0.81% |

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Vertex Pharmaceutic. It also helps investors analyze the systematic and unsystematic risks associated with investing in Vertex Pharmaceutic over a specified time horizon. Remember, high Vertex Pharmaceutic's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.

Also, please take a look at Vertex Pharmaceutic Backtesting, Vertex Pharmaceutic Valuation, Vertex Pharmaceutic Correlation, Vertex Pharmaceutic Hype Analysis, Vertex Pharmaceutic Volatility, Vertex Pharmaceutic History and analyze Vertex Pharmaceutic Performance. Vertex |

Please note that although Vertex Pharmaceutic alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Vertex Pharmaceutic did 0.25 better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Vertex Pharmaceutic stock's relative risk over its benchmark. Vertex Pharmaceutic has a beta of 0.93 . Let's try to break down what Vertex's beta means in this case. Vertex Pharmaceutic returns are very sensitive to returns on the market. As the market goes up or down, Vertex Pharmaceutic is expected to follow.

Vertex Pharmaceutic Enterprise Value over EBITDA is fairly stable at the moment as compared to the past year. Vertex Pharmaceutic reported Enterprise Value over EBITDA of 347.02 in 2021. Enterprise Value is likely to rise to about 17.8 **B**in 2022, whereas Book Value per Share is likely to drop 4.25 in 2022.

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

## Enterprise Value | ## 17.76 Billion |

## Vertex Pharmaceutic Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Vertex Pharmaceutic market risk premium is the additional return an investor will receive from holding Vertex Pharmaceutic long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vertex Pharmaceutic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Vertex Pharmaceutic's performance over market.α | 0.25 | β | 0.93 |

90 days against DJI

## Vertex Pharmaceutic expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Vertex Pharmaceutic's Buy-and-hold return. Our buy-and-hold chart shows how Vertex Pharmaceutic performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.## Vertex Pharmaceutic Market Price Analysis

Market price analysis indicators help investors to evaluate how Vertex Pharmaceutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceutic shares will generate the highest return on investment. By understating and applying Vertex Pharmaceutic stock market price indicators, traders can identify Vertex Pharmaceutic position entry and exit signals to maximize returns.

## Vertex Pharmaceutic Return and Market Media

The median price of Vertex Pharmaceutic for the period between Mon, May 16, 2022 and Sun, Aug 14, 2022 is 275.03 with a coefficient of variation of 5.83. The daily time series for the period is distributed with a sample standard deviation of 16.0, arithmetic mean of 274.58, and mean deviation of 13.08. The Stock received a lot of media exposure during the period. Price Growth (%) |

Timeline |

1 | Acquisition by Upadhyay Suketu of 1558 shares of Vertex Phar... | 05/19/2022 |

2 | Payment of 311 shares by Bozic Carmen of Vertex Pharmaceutic... | 06/02/2022 |

3 | Gene Editing Stocks To Consider After Bluebird Bios Breakthr... | 06/16/2022 |

4 | Where to Invest 10,000 in a Bear Market - Nasdaq | 06/22/2022 |

5 | ABBV 5 Strong Buy Pharmaceutical Stocks to Own for the Long ... | 06/29/2022 |

6 | EPS Estimate | 06/30/2022 |

7 | Why Top-Notch Biotech Stock Vertex Pharma Just Hit A Record ... | 07/06/2022 |

8 | 2 Biotech Stocks You Can Buy and Hold for the Next Decade - ... | 07/15/2022 |

9 | Acquisition by Mckenzie Diana of tradable shares of Vertex P... | 07/19/2022 |

10 | If You Invested 5,000 in Vertex Pharmaceuticals in 2017, Thi... | 07/20/2022 |

11 | Is This Vertex Pharmaceuticals Biggest News Yet - The Motley... | 07/25/2022 |

12 | Sale by Sangeeta Bhatia of tradable shares of Vertex Pharmac... | 08/02/2022 |

13 | EPS Reported | 08/04/2022 |

14 | Vertex Stock CF Monopoly, Looking To Expand - Seeking Alpha | 08/05/2022 |

15 | Sale by Liu Joy of 946 shares of Vertex Pharmaceutic | 08/10/2022 |

16 | Sale by Liu Joy of tradable shares of Vertex Pharmaceutic | 08/12/2022 |

## About Vertex Pharmaceutic Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Vertex Pharmaceutic has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

2019 | 2021 | 2022 (projected) | |

Long Term Debt to Equity | 0.0885 | 0.0505 | 0.0518 |

Interest Coverage | 79.54 | 49.15 | 53.03 |

## Vertex Pharmaceutic Upcoming Company Events

As portrayed in its financial statements, the presentation of Vertex Pharmaceutic's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vertex Pharmaceutic's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Vertex Pharmaceutic's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Vertex Pharmaceutic. Please utilize our Beneish M Score to check the likelihood of Vertex Pharmaceutic's management manipulating its earnings.

Upcoming Quarterly Report | 7th of February 2022 | |

Next Financial Report | 5th of May 2022 | |

Next Fiscal Quarter End | 31st of December 2021 | |

Next Fiscal Year End | 7th of February 2022 | |

Last Quarter Report | 30th of September 2021 | |

Last Financial Announcement | 31st of December 2020 |

## Build Portfolio with Vertex Pharmaceutic

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.## Build Diversified Portfolios

### Align your risk with return expectations

Also, please take a look at Vertex Pharmaceutic Backtesting, Vertex Pharmaceutic Valuation, Vertex Pharmaceutic Correlation, Vertex Pharmaceutic Hype Analysis, Vertex Pharmaceutic Volatility, Vertex Pharmaceutic History and analyze Vertex Pharmaceutic Performance. Note that the Vertex Pharmaceutic information on this page should be used as a complementary analysis to other Vertex Pharmaceutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

## Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.

Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | Go | |

Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | Go | |

Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities | Go | |

Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | Go | |

Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios | Go | |

Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm | Go | |

Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account | Go | |

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go | |

Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets | Go | |

Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios | Go | |

Technical AnalysisCheck basic technical indicators and analysis based on most latest market data | Go | |

Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated | Go |

Vertex Pharmaceutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.